ExLibris header image
SFX Logo
Title: Acetylcholinesterase-Fc Fusion Protein (AChE-Fc): A Novel Potential Organophosphate Bioscavenger with Extended Plasma Half-Life
Source:

Bioconjugate Chemistry [1043-1802] Noy Porat, Tal yr:2015


Collapse list of basic services Basic
Full text
Full text available via American Chemical Society Journals
GO
Document delivery
Request document via Library/Bibliothek GO
Users interested in this article also expressed an interest in the following:
1. Davis, Ian C. "Immunotherapies currently in development for the treatment of type 1 diabetes." Expert opinion on investigational drugs 24.10 (2015): 1331-41. Link to SFX for this item
2. ElEssawy, B. "Type 1 diabetes and T regulatory cells." Pharmacological research 98.Sp. Iss. SI (2015): 22-30. Link to SFX for this item
3. Lin, Q. "Construction of two Listeria ivanovii attenuated strains expressing Mycobacterium tuberculosis antigens for TB vaccine purposes." Journal of biotechnology 196-197 (2015): 20-26. Link to SFX for this item
4. Choe, Julie E. "Actin-based motility of bacterial pathogens: mechanistic diversity and its impact on virulence." Pathogens and Disease 74.8 (2016). Link to Full Text for this item Link to SFX for this item
5. Hu, C. "Type 1 diabetes and gut microbiota: Friend or foe?" Pharmacological research 98.Sp. Iss. SI (2015): 9-15. Link to SFX for this item
6. Li, K. "A fully human scFv phage display library for rapid antibody fragment reformatting." Protein engineering, design & selection 28.10 (2015): 307-16. Link to SFX for this item
7. Thakkar, Umang G. "Insulin-secreting adipose-derived mesenchymal stromal cells with bone marrow-derived hematopoietic stem cells from autologous and allogenic sources for type 1 diabetes mellitus." Cytotherapy 17.7 (2015): 940-7. Link to SFX for this item
8. Salunke, S. "Design and synthesis of novel anti-tuberculosis agents from the celecoxib pharmacophore." Bioorganic & medicinal chemistry 23.9 (2015): 1935-1943. Link to SFX for this item
9. Yu, A. "Selective IL-2 responsiveness of regulatory T cells through multiple intrinsic mechanisms support the use of low-dose IL-2 therapy in Type-1 diabetes." Diabetes 64.6 (2015): 2172-83. Link to SFX for this item
Select All Clear All

Expand list of advanced services Advanced
A service provided by the Library of the Wissenschaftspark Albert Einstein, Potsdam, Germany.
© 2005 SFX by Ex Libris Inc.